Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older at the time of signing consent.
- People who have been diagnosed with a solid tumour cancer, confirmed through laboratory analysis of tissue or cell samples.
- People who are already having Ataraxis testing done as part of their normal medical care.
- People for whom a tissue or cell sample from pathology is available.
- People who are willing and able to sign a written consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable or unwilling to provide informed consent.
- People whose Ataraxis test did not produce a usable result — for example, due to problems with the sample quality, a technical issue, or any other reason that meant no result could be reported.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jan Witowski, MD, PhD, Ataraxis AI
Phone: +1 (646) 832-2265
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
A large-scale, multi-site registry linking Ataraxis test results with short- and long-term clinical outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.